Sharon Laboratories, Ltd. (Ashdod, Israel), manufacturer of preservative solutions for the cosmetics and personal care markets, announced that it has signed a definitive agreement to acquire Italy-based specialty ingredients producer Res Pharma Industriale (RPI). Following the close of the acquisition, RPI’s technology, R&D, manufacturing, commercial development and customer service capabilities will be integrated into Sharon’s Personal Care business.
“The unique technical expertise each company brings will position us as a key partner for personal care and specifically for the wet-wipes industry. The combination of Sharon preservation and RES Pharma texturizing and concept formulation expertise will allow us to provide our customers with advanced support for developing sustainable, smart formulations,” says Naama Eylon, General Manager of Sharon Laboratories.
More details on the acquisition are included in the press release below my e-signature. We hope that you will consider sharing this news with your audience. If you are interested in speaking with a representative from Sharon Laboratories about the RPI acquisition, let me know and we can work on scheduling a time for you to connect.